Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential-Reference-Cited by-同舟云学术

Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential

Published:2023-03 Issue: Volume:28 Page:249-261
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

van Amerongen Rosa A.,Morton Laura T.,Chaudhari Umesh G.,Remst Dennis F.G.,Hagedoorn Renate S.,van den Berg Cathelijne W.,Freund Christian,Falkenburg J.H. Frederik,Heemskerk Mirjam H.M.

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. The emerging world of TCR-T cell trials against cancer: a systematic Review;Zhang;Technol. Cancer Res. Treat.,2019

2. T-cell receptor gene therapy: critical parameters for clinical success;Linnemann;J. Invest. Dermatol.,2011

3. Engineering strategies to enhance TCR-based adoptive T cell therapy;Rath;Cells,2020

4. T cell engineering for adoptive T cell therapy: safety and receptor avidity;D'Ippolito;Cancer Immunol. Immunother.,2019

5. T-cell receptor gene therapy – ready to go viral?;Karpanen;Mol. Oncol.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome;Nature Reviews Drug Discovery;2023-10-27

2. T-Cell Mediated Immune Rejection of Beta-2-Microglobulin Knockout Induced Pluripotent Stem Cell-Derived Kidney Organoids;Stem Cells Translational Medicine;2023-10-16

3. BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens;Genome Biology;2023-08-15

4. From the Classification of Stem Cells to the Release of Potential in Cell Therapies: Limits, Considerations and Future Aspects in Regenerative Medicine;Possibilities and Limitations in Current Translational Stem Cell Research;2023-06-21